2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil. [electronic resource]
Producer: 20190529Description: 495-503 p. digitalISSN:- 1558-3597
- Cardiology -- methods
- Child
- Child Advocacy
- Child Health -- legislation & jurisprudence
- Dose-Response Relationship, Drug
- Drug Development -- methods
- Drug and Narcotic Control -- organization & administration
- Humans
- Hypertension, Pulmonary -- drug therapy
- Mortality
- Off-Label Use -- legislation & jurisprudence
- Outcome Assessment, Health Care -- ethics
- Pediatrics -- methods
- Randomized Controlled Trials as Topic -- ethics
- Sildenafil Citrate -- administration & dosage
- Vasodilator Agents -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.